Kemp Proteins (formerly Kempbio) is a leading provider of gene-to-protein bioservices. For more than 20 years, Kemp’s team of protein problem-solvers has delivered best-in-class services that optimize productivity and mitigate risk for life sciences innovators developing protein-based products, including human and veterinary biopharmaceuticals, vaccines, and diagnostics. Kemp Proteins is a Six.02 Bioservices member company.
Location: United States, Maryland, Frederick
Employees: 11-50
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 23.01.2024 | ZoBio Sells to Oncodesign Services | BroadOak Capital Partners advised ZoBio on the sale of the company to Oncodesign Services. ZoBio is ... | broadoak.c... |
| 17.10.2022 | FDA Awards Kemp Proteins Contract to Develop Monoclonal Anti... | FREDERICK, Md. (PRWEB) October 17, 2022 Kemp Proteins announced today that it had been selected by t... | prweb.com/... |
| 22.06.2022 | Kemp Proteins Secures $5M Growth Financing from BroadOak Cap... | "Broadoak’s growth investment will enable us to acquire several S.I.P. fermenters, digitized co... | prweb.com/... |
| 12.04.2022 | Kemp Proteins’ Quality Management System receives ISO13485:2... | “Achieving these ISO certifications affirms that we have successfully implemented a QMS that conform... | prweb.com/... |
| 02.02.2021 | Kemp Proteins Elevates Carter Mitchell to Chief Scientific O... | “Since joining us in June 2020, Carter has had a major impact on our use of technology and new metho... | prweb.com/... |
| 08.12.2020 | Kemp Proteins Enter Strategic Partnership for Commercializat... | “The addition of a proprietary technology for Stable Cell Line Development represents an important m... | prweb.com/... |